T39.313

Clinical Causes: Intentional overdose or harm during an assault Accidental ingestion, especially in children or vulnerable individuals Misuse or abuse of pain relievers containing propionic acid derivatives Lack of awareness about medication potency or dosing errors Psychological factors leading to self-harm or external abuse involving these substances

Key Symptoms: Nausea and vomiting Abdominal pain or discomfort Dizziness or lightheadedness Headache Drowsiness or sedation Confusion or disorientation Respiratory difficulties Skin rashes or allergic reactions in some cases Seizures or tremors in severe poisonings

Diagnosis Path: Diagnosis typically involves a thorough medical history review and physical examination. Healthcare providers may perform laboratory tests, including blood and urine analyses, to detect the presence of propionic acid derivatives. Additional assessments such as electrocardiograms (ECGs) or imaging studies might be used to evaluate the impact on vital organs. The specific ICD-10 code T39.313 is used when poisoning is confirmed to be associated with an assault incident, indicating an intentional harm context.

Treatment Protocols: Management of poisoning by propionic acid derivatives includes supportive care to stabilize vital functions. Decontamination procedures, such as activated charcoal administration, may be performed if the exposure is recent. Treating specific symptoms like seizures or irregular heartbeat is essential. In severe cases, hospitalization may be necessary for monitoring and advanced interventions. Antidotes are not typically available for this class of medications, making symptomatic treatment paramount. Mental health support and counseling may be recommended if the poisoning results from intentional harm, such as assault or self-harm.